Results 111 to 120 of about 302,337 (268)

The persistence of chronic opioid use in patients with inflammatory bowel disease—A nationwide cohort study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Pain is common in patients with Crohn's disease (CD) and ulcerative colitis (UC), and a substantial proportion develop chronic opioid use (COU). We examined the persistence of COU over time and identified factors predicting persistent use. Methods This nationwide Danish cohort study included patients with an initial period of COU (definition: ≥3 ...
Bente Mertz Nørgård   +6 more
wiley   +1 more source

Correction to: The LUCID study: living with ulcerative colitis; identifying the socioeconomic burden in Europe

open access: yesBMC Gastroenterology, 2021
Leonardo Ruiz-Casas   +14 more
doaj   +1 more source

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale   +5 more
wiley   +1 more source

Phlegmonous Colitis after Cold Snare Polypectomy in an Immunosuppressed Patient: A Case Report [PDF]

open access: gold
Karen Kimura   +7 more
openalex   +1 more source

Involvement of peptidylarginine deiminase 2 and 4 in the pathogenesis of TNBS-induced colitis in mice

open access: diamond, 2023
Sugahara Ayaha   +6 more
openalex   +2 more sources

Suppressing Kv1.3 Ion Channel Activity with a Novel Small Molecule Inhibitor Ameliorates Inflammation in a Humanised Mouse Model of Ulcerative Colitis [PDF]

open access: hybrid, 2021
Anna‐Lena Unterweger   +12 more
openalex   +1 more source

Engineered Stable, Antibiotic‐Free, High‐Level Protein Expression in the Probiotic Chassis Escherichia coli Nissle 1917

open access: yesBiotechnology and Bioengineering, EarlyView.
The probiotic E. coli Nissle 1917 was engineered to enable stable and antibiotic free protein expression platforms using native plasmids. Further modification aids in the production of high‐level protein expression for antimicrobial secretion whose activity is comparable to industry standard E. coli BL21.
Halimatun Sakdiah Zainuddin   +2 more
wiley   +1 more source

Pseudomembranous colitis in children: Experience of a university hospital in Korea

open access: diamond, 2010
Jae Hyun Park   +4 more
openalex   +1 more source

PTH-110 Colitis on CT – does this mean inflammatory bowel disease? [PDF]

open access: gold, 2019
Rajan Patel   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy